Relevant bibliographies by topics / Rheumatoid arthritis Rheumatoid arthritis Osteoarthritis Osteoarthritis Hydrocortisone / Books
To see the other types of publications on this topic, follow the link: Rheumatoid arthritis Rheumatoid arthritis Osteoarthritis Osteoarthritis Hydrocortisone.

Books on the topic 'Rheumatoid arthritis Rheumatoid arthritis Osteoarthritis Osteoarthritis Hydrocortisone'

Author: Grafiati
Published: 4 June 2021
Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Rheumatoid arthritis Rheumatoid arthritis Osteoarthritis Osteoarthritis Hydrocortisone.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Fabio, Anthony Di. Arthritis: About osteoarthritis and rheumatoid disease, including rheumatoid arthritis. Franklin, TN: Arthritis Trust of America, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Reid, David M., and Colin G. Miller, eds. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. London: Springer London, 2008. http://dx.doi.org/10.1007/978-1-84628-742-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dixon, Tracy. National indicators for monitoring osteoarthritis, rheumatoid arthritis, and osteoporosis. Canberra: Australian Institute of Health and Welfare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dixon, Tracy. National indicators for monitoring osteoarthritis, rheumatoid arthritis, and osteoporosis. Canberra: Australian Institute of Health and Welfare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chang-Miller, April. Mayo clinic on arthritis. Rochester, Minnesota: Mayo Clinic, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bruno, Michael A. Arthritis in color: Advanced imaging of arthritis. Philadelphia, PA: Saunders/Elsevier, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bruno, Michael A. Arthritis in color: Advanced imaging of arthritis. Philadelphia, PA: Saunders/Elsevier, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Maetzel, Andreas. Economic assessment: Celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rahman, Naila. Arthritis and musculoskeletal conditions in Australia 2005: With a focus on osteoarthritis, rheumatoid arthritis and osteoporosis. Canberra, A.C.T: Australian Institute of Health and Welfare, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Prescott, Vanessa. Data sources for monitoring arthritis and musculoskeletal conditions. Canberra, [A.C.T.]: Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Australian Institute of Health and Welfare. A snapshot of osteoporosis in Australia 2011. Canberra: Australian Institute of Health and Welfare, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Maetzel, Andreas. The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Hunder, Gene G. Guide to managing arthritis. Rochester, Minn: Mayo Clinic, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Peters, Tim. Understanding Osteoarthritis/Rheumatoid Arthritis. Tim Peters & Co Inc, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

1951-, Reid David, and Miller Colin G. 1960-, eds. Clinical trials in rheumatoid arthritis and osteoarthritis. London: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Alan, Sarokhan, ed. Understanding rheumatoid arthritis (RA) ; and, Understanding osteoarthritis (OA). Gladstone, NJ: T. Peters, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Society, American Pain, ed. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. Glenview, IL: American Pain Society, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Clinical Trials in Rheumatoid Arthritis and Osteoarthritis (Clinical Trials). Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

G, Hunder Gene, and Mayo Foundation for Medical Education and Research., eds. Mayo Clinic on arthritis. Rochester, Minn: Mayo Clinic, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Clinic, Mayo. Mayo Clinic on Arthritis (Mayo Clinic on Health). 2nd ed. Mayo Clinic Trade Paper, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Hunder, M. D. Gene. Mayo Clinic Straight Talk on Arthritis. Mayo Clinic Health Information, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Author), Mayo Clinic (Corporate, and Gene G. Hunder (Editor), eds. Mayo Clinic on Arthritis (Mayo Clinic on Health). 2nd ed. Mason Crest Publishers, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

C, Singleton Mary, and Branch Eleanor F, eds. Physical therapy and the arthritis patient: Clinical aspects and approaches to management. New York: Haworth Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

The rheumatoid arthritis cookbook: Anti-inflammatory recipes to fight flares & fatigue. Callisto Media Inc., 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ontario Musculoskeletal Therapeutics Review Panel. and Ontario Program for Optimal Therapeutics., eds. Ontario treatment guidelines for osteoarthritis, rheumatoid arthritis, and acute musculoskeletal injury. Toronto: Queen's Printer of Ontario, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

MD, Brian Kotzin, and Herbert Kaplan MD. Patient Education Booklets: What You Should Know About Arthritic Disorders: Osteoarthritis/rheumatoid Arthritus/systemic Lupus Erythematosis (Patient Education Booklets). Mosby International, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

L, Sutton Amy, ed. Arthritis sourcebook: Basic consumer health information about the risk factors, symptoms, diagnosis, and treatment of osteoarthritis, rheumatoid arthritis, juvenile arthritis, gout, infectious ... 3rd ed. Detroit, MI: Omnigraphics, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Sutton, Amy L. Arthritis Sourcebook: Basic Consumer Health Information About Osteoarthritis, Rheumatoid Arthritis, Other Rheumatic Disorders, Infectious Forms of Arthritis, and Diseases w (Health Reference Series). Omnigraphics, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Rubin, Jordan, and Joseph Brasco. The Great Physician's Rx for Arthritis (Great Physican's RX). Thomas Nelson, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Guía De La Clí­nica Mayo Sobre ARTRITIS. Plaza & Janes Editories Sa, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Pybus, Paul K. Intraneural injections for rheumatoid arthritis and osteoarthritis ;: And, a reprint for physicians and layman: The control of pain in arthritis of the knee. Rheumatoid Disease Foundation, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

de Vlam, Kurt. Overview of psoriatic arthritis pathogenesis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198737582.003.0004.

Full text
Abstract:
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis occurring in patients with psoriasis. Some consider it as part of the heterogeneous group of diseases unified in the concept of spondyloarthritis (SpA). At least some subtypes, such as the oligoarticular and axial subtypes, can be classified as SpA. The aetiology and pathogenesis are poorly understood. An enthesitis-based model was proposed to unify skin and joint manifestation and to differentiate PsA from other rheumatic diseases such as rheumatoid arthritis and osteoarthritis. The development of PsA results from the interplay of genes, the immune response, and interaction with environmental factors. The fact that more than 80% of patients with PsA have precedent or simultaneous psoriasis suggests that the skin disease is almost a ‘condicio sine qua non’ for the development of PsA.
APA, Harvard, Vancouver, ISO, and other styles
33

R, Cook Allan, ed. Arthritis sourcebook: Basic information about specific forms of arthritis and related disorders including rheumatoid arthritis, osteoarthritis, gout, polymyalgia rheumatica, psoriatic arthritis, spondyloarthropathies, juvenile rheumatoid arthritis, and juvenile ankylosing spondylitis along with treatment options from over-the-counter and prescription drugs to surgery and alternative measures and coping strategies to ease pain, fatigue, and stress. Detroit, MI: Omnigraphics, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Weatherby, Craig, and Leonid Gordin. The Arthritis Bible: A Comprehensive Guide to Alternative Therapies and Conventional Treatments for Arthritic Diseases. Healing Arts Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

R, Cook Allan, ed. Arthritis sourcebook: Basic consumer health information about specific forms of arthritis and related disorders including rheumatoid arthritis, osteoarthritis, gout, polymyalgia rheumatica, psoriatic arthritis, spondyloarthropathies, juvenile rheumatoid arthritis, and juvenile ankylosing spondylitis, along with information about medical, surgical, and alternative treatment options, and including strategies for coping with pain, fatigue, and stress. Detroit, MI: Omnigraphics, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Platt, Philip, and Ismael Atchia. Injection therapy. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0087.

Full text
Abstract:
Joint and soft tissue injections with glucocorticoids and other agents remain a critical aspect of the management of musculoskeletal conditions. Injection therapy has previously consisted mainly of glucocorticoid and local anaesthetic, but other agents such as hyaluronic acid, radioactive agents, plasma-rich products, and biologics have also been introduced in the practice of musculoskeletal clinicians. Overall glucocorticoid injection remains the most widely performed procedure, and is an effective treatment for an inflamed joint or soft tissue. This procedure has been widely used for at least five decades. Hydrocortisone was the initial steroid used but longer-acting steroid agents are now favoured for large joints. There is evidence of efficacy not only for inflammatory arthritis conditions, but also for osteoarthritis. There are certain contraindications for injection therapy. Hyaluronic acid (viscosupplementation) injection has become part of the management of osteoarthritis. More recently other agents such as disease-modifying anti-rheumatic drugs (DMARDs) and biologics have been injected with varying degree of success. The ability to deliver an injection accurately depends on appropriate knowledge of the anatomy and, as for any procedures, the experience and skill of the clinician. The approach to different joints and soft tissue structures is described in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
37

Whitney, Catherine, and Peter J. D'Adamo. Arthritis: Fight it with the Blood Type Diet: The Individualized Plan for Defeating the Pain of Osteoarthritis, Rheumatoid (Dr. Peter D'adamo's Eat Right for Your Type Health Library). Berkley, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Wiffen, Philip, Marc Mitchell, Melanie Snelling, and Nicola Stoner. Therapy-related issues: musculoskeletal. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198735823.003.0024.

Full text
Abstract:
This chapter outlines information relevant to clinical pharmacists related to musculoskeletal diseases and is loosely based on the British National Formulary, Chapter 10. In particular, this chapter covers rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, osteoporosis, and gout.
APA, Harvard, Vancouver, ISO, and other styles
39

Carton, James. Osteoarticular pathology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759584.003.0017.

Full text
Abstract:
This chapter discusses osteoarticular pathology, including osteoporosis, osteopetrosis, rickets and osteomalacia, Paget’s disease, osteomyelitis, osteoarthritis, rheumatoid arthritis, spondyloarthropathies, crystal arthropathies, septic arthritis, periprosthetic reactions, soft tissue and bone tumours, benign soft tissue tumours, malignant soft tissue tumours, benign bone tumours, and malignant bone tumours.
APA, Harvard, Vancouver, ISO, and other styles
40

Jolly, Elaine, Andrew Fry, and Afzal Chaudhry, eds. Rheumatology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199230457.003.0019.

Full text
Abstract:
Chapter 19 covers the basic science and clinical topics relating to rheumatology which trainees are required to learn as part of their basic training and demonstrate in the MRCP. It covers basic science, the synovium, autoantibodies, osteoarthritis, rheumatoid arthritis, septic arthritis, crystal arthropathies, spondyloarthritides, psoriatic arthritis, low back pain, systemic lupus erythematosus, systemic sclerosis, polymyositis/dermatomyositis, Sjögren syndrome, giant cell arteritis/polymyalgia rheumatic, polyarteritis nodosa, Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis), granulomatosis with polyangiitis (Wegener), treating systemic vasculitis, relapsing polychondritis, and Behҫet disease.
APA, Harvard, Vancouver, ISO, and other styles
41

Simon, Lee S., and Marc C. Hochberg. Non-steroidal anti-inflammatory drugs. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0030.

Full text
Abstract:
Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse group of compounds that share three cardinal characteristics: they are anti-inflammatory, analgesic, and antipyretic. They are approved by regulatory authorities for the treatment of patients with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout, and some forms of juvenile idiopathic arthritis. There are at least 20 chemically different NSAIDs currently available in Europe and the United States. These include not only the ‘traditional’ non-selective cyclooxygenase (COX) inhibitors that inhibit both the COX-1 and COX-2 enzymes but also the COX-2 selective inhibitors. This chapter gives a background of NSAIDs, including the mechanism of action, pharmacology and adverse effects (including hypersensitivity and gastrointestinal, cardiovascular thrombotic, and renal adverse effects), before summarizing the use of NSAIDs in patients with osteoarthritis.
APA, Harvard, Vancouver, ISO, and other styles
42

Michet, Clement J., Kenneth G. Moder, and William W. Ginsburg. Rheumatology. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0681.

Full text
Abstract:
Major rheumatologic diseases are reviewed in detail, including symptoms, diagnosis, and treatment. Rheumatoid arthritis, Sjogren syndrome, Felty syndrome, osteoarthritis, fibromyalgia, and vasculitic syndromes like giant cell arteritis, polyarteritis nodosa, Takayasu arteritis, and Wegener granulomatosis are included. Drugs used to treat rheumatic disease are also highlighted. They include NSAIDs, antimalarials, and glucocorticosteroids. Crystalline arthropathies, such as hyperuricemia and gout, are another class of rheumatologic disease, as are spondyloarthropathies, systemic lupus erythematosus, uveitis, and Behcet syndrome.
APA, Harvard, Vancouver, ISO, and other styles
43

Redmond, Anthony C., and Philip S. Helliwell. Foot and ankle. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0156.

Full text
Abstract:
Foot and ankle problems have been the subject of major advances in the rheumatology in recent years. This chapter reviews the anatomy of the foot and covers the manifestations of foot pathology for the major conditions: rheumatoid arthritis, osteoarthritis, the seronegative arthritides, connective tissue disease, crystal diseases, and miscellaneous conditions including hypermobility syndrome. Relevant local conditions including plantar fasciitis, tendinopathy, and neuroma are addressed separately. The principles of assessing and treating the foot and ankle in rheumatology are covered, along with the relevant specific approaches best suited to dealing with problems associated with the major conditions.
APA, Harvard, Vancouver, ISO, and other styles
44

Redmond, Anthony C., and Philip S. Helliwell. Foot and ankle. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199642489.003.0156_update_001.

Full text
Abstract:
Foot and ankle problems have been the subject of major advances in the rheumatology in recent years. This chapter reviews the anatomy of the foot and covers the manifestations of foot pathology for the major conditions: rheumatoid arthritis, osteoarthritis, the seronegative arthritides, connective tissue disease, crystal diseases, and miscellaneous conditions including hypermobility syndrome. Relevant local conditions including plantar fasciitis, tendinopathy, and neuroma are addressed separately. The principles of assessing and treating the foot and ankle in rheumatology are covered, along with the relevant specific approaches best suited to dealing with problems associated with the major conditions.
APA, Harvard, Vancouver, ISO, and other styles
45

Shankar, Hariharan, and Marina Vardanyan. Hip Joint Injections: Ultrasound. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199908004.003.0040.

Full text
Abstract:
Hip pain is a common presentation in medical practice, and causes include osteoarthritis, rheumatoid arthritis, congenital hip abnormalities, and trauma. Chronic hip pain significantly alters the patient’s quality of life and commonly leads to disability due to damage of structural elements of the hip joint. Ultrasound-guided hip injections are a viable alternative to fluoroscopically guided hip injections. Ultrasound imaging of the hip is a highly sensitive method for detecting joint pathology and periarticular pathology as well. This method is fast, safe, can be used in an ambulatory setting, and allows precise deposition of injectate into the hip joint.
APA, Harvard, Vancouver, ISO, and other styles
46

Strand, Vibeke, Jeremy Sokolove, and Alvina D. Chu. Design of clinical trials in rheumatology. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0030.

Full text
Abstract:
Development of new therapies for rheumatic diseases requires a series of randomized controlled trials (RCTs) progressing from phase 1, 'first-in-human' to generate initial safety, pharmacokinetic (PK) and pharmacodynamic (PD) data; to phase 2, proof of concept for efficacy with safety and PK/PD data; and phase 3, designed to demonstrate definitive efficacy and safety to support regulatory approval. Important aspects of RCT designs include sample size estimations, treatment allocation, rescue, blinding, and statistical analyses of prespecified endpoints to preserve trial integrity. Over the past 15 years, significant progress has been made in the design of RCTs in rheumatoid arthritis (RA). Similarly, development and validation of composite outcome measures in psoriatic arthritis, ankylosing spondylitis, gout, and osteoarthritis have furthered trial design and treatment approvals. RCTs in systemic lupus erythematosus and other multisystem, heterogeneous diseases pose more challenges. Trial design will continue to evolve as promising therapies are introduced into the clinic.
APA, Harvard, Vancouver, ISO, and other styles
47

Strand, Vibeke, Jeremy Sokolove, and Alvina D. Chu. Design of clinical trials in rheumatology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0030_update_001.

Full text
Abstract:
Development of new therapies for rheumatic diseases requires a series of randomized controlled trials (RCTs) progressing from phase 1, ’first-in-human’ to generate initial safety, pharmacokinetic (PK) and pharmacodynamic (PD) data; to phase 2, proof of concept for efficacy with safety and PK/PD data; and phase 3, designed to demonstrate definitive efficacy and safety to support regulatory approval. Important aspects of RCT designs include sample size estimations, treatment allocation, rescue, blinding, and statistical analyses of prespecified endpoints to preserve trial integrity. Over the past 15 years, significant progress has been made in the design of RCTs in rheumatoid arthritis (RA). Similarly, development and validation of composite outcome measures in psoriatic arthritis, ankylosing spondylitis, gout, and osteoarthritis have furthered trial design and treatment approvals. RCTs in systemic lupus erythematosus and other multisystem, heterogeneous diseases pose more challenges. Trial design will continue to evolve as promising therapies are introduced into the clinic.
APA, Harvard, Vancouver, ISO, and other styles
48

Strand, Vibeke, Jeremy Sokolove, and Alvina D. Chu. Design of clinical trials in rheumatology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199642489.003.0030_update_002.

Full text
Abstract:
Development of new therapies for rheumatic diseases requires a series of randomized controlled trials (RCTs) progressing from phase 1, ’first-in-human’ to generate initial safety, pharmacokinetic (PK) and pharmacodynamic (PD) data; to phase 2, proof of concept for efficacy with safety and PK/PD data; and phase 3, designed to demonstrate definitive efficacy and safety to support regulatory approval. Important aspects of RCT designs include sample size estimations, treatment allocation, rescue, blinding, and statistical analyses of prespecified endpoints to preserve trial integrity. Over the past 15 years, significant progress has been made in the design of RCTs in rheumatoid arthritis (RA). Similarly, development and validation of composite outcome measures in psoriatic arthritis, ankylosing spondylitis, gout, and osteoarthritis have furthered trial design and treatment approvals. RCTs in systemic lupus erythematosus and other multisystem, heterogeneous diseases pose more challenges. Trial design will continue to evolve as promising therapies are introduced into the clinic.
APA, Harvard, Vancouver, ISO, and other styles
49

Hillegass, M. Gabriel, Anthony A. Tucker, and Antonio Quidgley-Nevares. Musculoskeletal Pain. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190217518.003.0012.

Full text
Abstract:
This chapter on musculoskeletal pain is composed of a question-and-answer bank that encompasses the breadth of the fund of knowledge required for the evaluation and management of various chronic musculoskeletal pain syndromes. Not only do probing questions with concise and informative answer explanations challenge the reader’s knowledge base but also references for further reading and mastery of the subject are provided. Topics covered include epidemiology, disability, rehabilitation, anatomy and physiology (including neurophysiology and mediators of inflammation), and the musculoskeletal exam. The pathophysiology, diagnosis, and management of musculoskeletal pain conditions such as common orthopedic and occupational injuries, osteoarthritis, chronic tissue pain states, and various autoimmune diseases (e.g., rheumatoid arthritis) are also expertly reviewed. These high-yield questions correspond to the musculoskeletal pain section of the American Board of Medical Specialties Pain Medicine Content Outline.
APA, Harvard, Vancouver, ISO, and other styles
50

Clunie, Gavin P. R., Nick Wilkinson, Elena Nikiphorou, and Deepak Jadon, eds. Oxford Handbook of Rheumatology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198728252.001.0001.

Full text
Abstract:
The Oxford Handbook of Rheumatology, 4th edition, has been expanded and improved to incorporate paediatric and adolescent rheumatology. The format of the book is retained. The first four chapters offer a pragmatic guide to evaluating rheumatic and musculoskeletal diseases, showing how a differential diagnosis can be formed on the basis of symptoms, examination, and investigation findings, both for regional musculoskeletal and systemic generalized conditions. Part II comprises chapters on all the major rheumatic and bone diseases and autoimmune connective tissue diseases, such as rheumatoid arthritis, osteoarthritis, spondyloarthritis, systemic lupus erythematosus (lupus), crystal-induced musculoskeletal disease, juvenile idiopathic arthritis, antiphospholipid syndrome, Sjögren’s syndrome, osteoporosis, vasculitis, spinal disorders and back pain, and chronic pain syndromes, as well as new chapters on rare diseases and hereditary disorders. Part II includes chapters on drugs used in rheumatology practice, glucocorticoid injection therapy, and rheumatological emergencies. All chapters are updated to include details on paediatric and adolescent rheumatology, dealt with fairly cursorily in previous Handbook editions. Greatly expanded chapters are included on drugs used in rheumatology, pain syndromes, and the presentation of paediatric and adolescent disease.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Rheumatoid arthritis Rheumatoid arthritis Osteoarthritis Osteoarthritis Hydrocortisone' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography